Option chain shows key data for Belite Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Belite Bio.

Belite Bio (NASDAQ:BLTE) Stock, Option Chain

BELITE BIO INC - ADR

Belite Bio

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Munich,,Bavaria,,Germany,-,March,31,2023:,Dycom,Industries,Provides

News

Intraday Update

Markets

Movers

Trading Ideas

ACLX

ARQQ

BLTE

CRWV

GOOS

KEYS

LAES

Next Technology Holding Inc. - Ordinary Shares

NXTT

XPEV

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday

biotech shutter

Analyst Color

Earnings

Analyst Ratings

Tech

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials

Penny Stocks

Small Cap

AGBA

AGIL

AIXI

AURC

BEDU

BLIN

BSAQ

BTAI

CLAR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CURO

CWCO

EBIX

ELOX

ERAS

ESGL

FATH

FTRE

FWAC

HRYU

JTAI

LICY

LWAY

Airspan Networks Holdings Inc. Common Stock

MIMO

NAAS

NKLA

ORGN

ORIC

RVLP

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDPI

SMMT

SNCE

SOUN

SVFD

TDUP

TSHA

VALN

VCIG

VEDU

XXII

YELL

ZYNE

Gainers


	Zynerba Pharmaceuticals, Inc.  (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.


Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Belite Bio, Inc - American Depositary Shares

Belite Bio Inc

Press Releases

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Health Care

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

Belite Bio to Participate in Four Upcoming Investor Conferences

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

General

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

ABBNY

BDOUY

BVNRY

CLCGY

EPOAY

FPAFY

ICAGY

IFNNY

VIOT

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

ANI Pharmaceuticals

Axsome Therapeutics

BGM Group

Bausch Health Companies Inc. Common Stock

Bausch Health Companies

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Harrow

Indivior

Innoviva

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Liquidia

Ocular Therapeutix

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Perrigo

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Tarsus Pharmaceuticals

HC Wainwright & Co.

Benchmark

Maxim Group

SVB Leerink

Comments

Belite Bio

Belite Bio (BLTE) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell